0 38

Cited 0 times in

European validation of the Yonsei Gastric Cancer Prognosis Prediction Model after gastrectomy: Validation with the Netherlands Cancer Registry

Authors
 Hylke J.F. Brenkman  ;  Minah Cho  ;  Jelle P. Ruurda  ;  Kijun Song  ;  Taeil Son  ;  Hyoung-il Kim  ;  Sung Hoon Noh  ;  Richard van Hillegersberg  ;  Woo Jin Hyung 
Citation
 EJSO, Vol.45(6) : 983-988, 2019 
Journal Title
 EJSO 
ISSN
 0748-7983 
Issue Date
2019
Keywords
Gastrectomy ; Gastric cancer ; Nomogram ; Staging
Abstract
BACKGROUND: Recently, a novel model predicting 5-year survival after gastrectomy was developed, the Yonsei Gastric Cancer Prognosis Prediction Model, to overcome limitations of the tumor-node-metastases (TNM) staging system. This study aimed to validate this model in a European cohort. METHODS: All patients who underwent gastrectomy for gastric cancer were selected from the Netherlands Cancer Registry (2005-2015). Patients with 30-day mortality, co-existing cancer, neoadjuvant therapy, or missing data were excluded. The prediction model included gender, age, resection type, pT-stage, pM-stage, number of retrieved lymph nodes, number of metastatic lymph nodes, and tumor histology. The model was validated and compared to the 7th TNM staging system using calibration plots and the concordance index (c-statistic with 95% confidence interval (CI)). RESULTS: From the 5748 patients who underwent gastrectomy, 2253 were included in this study. Mean age was 72.1 years, most patients had advanced gastric cancer (88%), and in 1102 patients (49%) no proper TNM staging could be performed since <16 lymph nodes were retrieved. Median overall survival was 24.6 months, and the 5-year overall survival was 30%, respectively. Model calibration was accurate in predicting 5-year overall survival, and the degree of discrimination was high (c-statistic = 0.807, 95% CI (0.787-0.826)). The model was superior to the TNM staging system in patients who could be properly staged: c-statistic = 0.861, 95% CI (0.838-0.885) vs. 0.711, 95% CI (0.692-0.729), p < 0.0001. CONCLUSION: The Yonsei Gastric Cancer Prognosis Prediction Model was superior over the TNM staging system in predicting prognosis after gastrectomy in a European cohort, although it is not applicable to patients treated by neoadjuvant therapy.
Full Text
https://www.sciencedirect.com/science/article/pii/S0748798319300010
DOI
10.1016/j.ejso.2019.01.001
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers
Yonsei Authors
Kim, Hyoung Il(김형일) ORCID logo https://orcid.org/0000-0002-6134-4523
Noh, Sung Hoon(노성훈) ORCID logo https://orcid.org/0000-0003-4386-6886
Son, Tae Il(손태일) ORCID logo https://orcid.org/0000-0002-0327-5224
Cho, Minah(조민아) ORCID logo https://orcid.org/0000-0003-3011-5813
Hyung, Woo Jin(형우진) ORCID logo https://orcid.org/0000-0002-8593-9214
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/170356
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse